Kdo2-Lipid A / ATP gene array data - treatment:control ratiosKEGG pathway: Linoleic acid metabolism (mmu00591)| Legend: |  : View data/graphs for replicates |
|---|
|
| Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
| Alox15 |  |
NM_009660 |
arachidonate 15-lipoxygenase (Alox15), mRNA [NM_009660] |
KLA | 1.02 |
.93 |
.98 |
.96 |
.98 |
.95 |
.87 |
| ATP | .92 |
.95 |
1.09 |
1.01 |
.98 |
1.00 |
.97 |
| KLA/ATP | .97 |
.95 |
.98 |
.94 |
.98 |
.97 |
.92 |
|
| Cyp1a2 |  |
NM_009993 |
cytochrome P450, family 1, subfamily a, polypeptide 2 (Cyp1a2), mRNA [NM_009993] |
KLA | 1.01 |
.99 |
.98 |
1.02 |
.97 |
.97 |
1.00 |
| ATP | 1.01 |
.98 |
1.03 |
1.01 |
1.04 |
1.02 |
1.04 |
| KLA/ATP | .99 |
1.00 |
1.05 |
1.03 |
.98 |
.97 |
.99 |
|
| Cyp2c29 |  |
NM_007815 |
cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815] |
KLA | 1.01 |
.95 |
1.06 |
1.12 |
1.01 |
1.02 |
1.12 |
| ATP | 1.03 |
1.02 |
1.01 |
1.06 |
.98 |
.98 |
.96 |
| KLA/ATP | 1.09 |
1.14 |
1.02 |
.98 |
.99 |
.98 |
.98 |
|
| Cyp2c37 |  |
NM_010001 |
cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001] |
KLA | 1.27 |
1.43 |
1.64 |
1.52 |
1.65 |
1.43 |
1.45 |
| ATP | .99 |
.96 |
1.03 |
1.13 |
1.10 |
1.03 |
1.27 |
| KLA/ATP | 1.37 |
1.49 |
1.22 |
1.46 |
1.16 |
1.12 |
1.24 |
|
| Cyp2c38 |  |
NM_010002 |
cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002] |
KLA | 1.01 |
1.06 |
.98 |
.96 |
1.07 |
.98 |
.97 |
| ATP | 1.01 |
1.09 |
1.04 |
.98 |
1.00 |
1.03 |
.98 |
| KLA/ATP | 1.03 |
.98 |
1.03 |
1.04 |
1.00 |
1.00 |
1.01 |
|
| Cyp2c39 |  |
NM_010003 |
cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003] |
KLA | 1.04 |
1.01 |
.97 |
1.00 |
.99 |
1.01 |
.98 |
| ATP | 1.04 |
1.07 |
.95 |
1.00 |
.96 |
1.03 |
1.01 |
| KLA/ATP | 1.03 |
1.01 |
1.02 |
1.01 |
1.05 |
1.05 |
.99 |
|
| Cyp2c40 |  |
NM_010004 |
cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004] |
KLA | .96 |
1.06 |
1.05 |
1.03 |
.99 |
1.01 |
1.02 |
| ATP | .96 |
1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.99 |
| KLA/ATP | 1.06 |
1.03 |
1.04 |
.98 |
1.05 |
1.01 |
.97 |
|
| Cyp2c44 |  |
NM_001001446 |
cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446] |
KLA | .98 |
1.04 |
.93 |
1.05 |
1.01 |
.93 |
.94 |
| ATP | 1.02 |
1.01 |
1.01 |
1.04 |
1.02 |
1.02 |
1.00 |
| KLA/ATP | .93 |
.95 |
1.00 |
1.05 |
1.07 |
1.01 |
1.01 |
|
| Cyp2c54 |  |
NM_206537 |
cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537] |
KLA | .98 |
.99 |
1.04 |
.97 |
1.06 |
1.03 |
1.04 |
| ATP | .99 |
.98 |
1.10 |
1.03 |
1.03 |
.98 |
1.03 |
| KLA/ATP | 1.02 |
1.04 |
.89 |
.98 |
.99 |
.93 |
.99 |
|
| Cyp2c55 |  |
NM_028089 |
cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089] |
KLA | .97 |
1.02 |
1.01 |
.99 |
.99 |
1.00 |
.94 |
| ATP | 1.04 |
.98 |
1.09 |
.97 |
1.05 |
.99 |
1.06 |
| KLA/ATP | 1.04 |
1.01 |
1.15 |
1.03 |
1.05 |
1.05 |
1.09 |
|
| Cyp2c65 |  |
AK008688 |
adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688] |
KLA | .95 |
.97 |
1.02 |
1.00 |
.97 |
1.10 |
1.04 |
| ATP | .98 |
1.05 |
1.00 |
1.10 |
.98 |
.99 |
1.03 |
| KLA/ATP | .96 |
.97 |
.99 |
1.01 |
1.03 |
1.04 |
1.03 |
|
| Cyp2c66 |  |
NM_001011707 |
cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707] |
KLA | 1.03 |
1.04 |
.99 |
1.00 |
1.06 |
1.11 |
1.01 |
| ATP | .97 |
1.01 |
1.03 |
1.00 |
.98 |
1.03 |
1.04 |
| KLA/ATP | 1.08 |
.97 |
1.15 |
1.02 |
1.04 |
1.06 |
1.08 |
|
| Cyp2c70 |  |
NM_145499 |
cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499] |
KLA | 1.05 |
.94 |
.95 |
.86 |
1.06 |
.96 |
.99 |
| ATP | 1.01 |
.98 |
.69 |
.69 |
.97 |
.87 |
1.09 |
| KLA/ATP | 1.00 |
.97 |
.74 |
.74 |
.81 |
.86 |
1.17 |
|
| Cyp2e1 |  |
NM_021282 |
cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1), mRNA [NM_021282] |
KLA | .99 |
1.03 |
1.05 |
1.01 |
.99 |
1.06 |
1.00 |
| ATP | .96 |
.93 |
.98 |
1.05 |
1.01 |
1.03 |
1.10 |
| KLA/ATP | 1.04 |
.99 |
1.02 |
1.00 |
1.05 |
1.04 |
.99 |
|
| Cyp2j11 |  |
NM_001004141 |
cytochrome P450, family 2, subfamily j, polypeptide 11 (Cyp2j11), mRNA [NM_001004141] |
KLA | .95 |
1.02 |
1.07 |
.95 |
.95 |
.92 |
.83 |
| ATP | .95 |
1.02 |
1.05 |
.93 |
.92 |
.90 |
1.00 |
| KLA/ATP | 1.05 |
.96 |
1.00 |
.97 |
.90 |
.82 |
.86 |
|
| Cyp2j13 |  |
NM_145548 |
cytochrome P450, family 2, subfamily j, polypeptide 13 (Cyp2j13), mRNA [NM_145548] |
KLA | 1.01 |
.99 |
.98 |
1.00 |
.98 |
.96 |
.92 |
| ATP | .99 |
1.03 |
1.01 |
.98 |
.95 |
1.01 |
1.02 |
| KLA/ATP | .96 |
1.03 |
1.02 |
1.03 |
.96 |
.95 |
.96 |
|
| Cyp2j5 |  |
NM_010007 |
cytochrome P450, family 2, subfamily j, polypeptide 5 (Cyp2j5), mRNA [NM_010007] |
KLA | 1.00 |
.99 |
1.05 |
1.01 |
1.00 |
1.06 |
1.06 |
| ATP | .99 |
1.00 |
1.03 |
1.09 |
1.00 |
1.03 |
1.01 |
| KLA/ATP | 1.03 |
.98 |
1.09 |
1.11 |
1.06 |
1.09 |
1.01 |
|
| Cyp2j9 |  |
NM_028979 |
cytochrome P450, family 2, subfamily j, polypeptide 9 (Cyp2j9), mRNA [NM_028979] |
KLA | .84 |
.88 |
.97 |
.91 |
.75 |
.66 |
.66 |
| ATP | 1.10 |
.98 |
.99 |
.92 |
.90 |
.73 |
.64 |
| KLA/ATP | .88 |
.95 |
.93 |
.86 |
.80 |
.78 |
.59 |
|
| Cyp3a11 |  |
NM_007818 |
cytochrome P450, family 3, subfamily a, polypeptide 11 (Cyp3a11), mRNA [NM_007818] |
KLA | .96 |
.94 |
1.06 |
1.04 |
.96 |
.94 |
.97 |
| ATP | 1.00 |
1.01 |
.94 |
.95 |
.94 |
.92 |
.98 |
| KLA/ATP | .98 |
1.06 |
1.06 |
.98 |
.88 |
.93 |
.91 |
|
| Cyp3a13 |  |
NM_007819 |
cytochrome P450, family 3, subfamily a, polypeptide 13 (Cyp3a13), mRNA [NM_007819] |
KLA | .99 |
.98 |
.98 |
1.03 |
.97 |
1.01 |
1.07 |
| ATP | 1.00 |
1.01 |
1.01 |
1.04 |
1.01 |
.99 |
1.00 |
| KLA/ATP | 1.06 |
1.01 |
1.00 |
1.08 |
1.09 |
1.01 |
1.09 |
|
| Cyp3a16 |  |
NM_007820 |
cytochrome P450, family 3, subfamily a, polypeptide 16 (Cyp3a16), mRNA [NM_007820] |
KLA | .95 |
.99 |
.96 |
.96 |
1.00 |
1.03 |
.99 |
| ATP | 1.04 |
1.03 |
.98 |
.97 |
.98 |
1.03 |
1.01 |
| KLA/ATP | .96 |
.91 |
.96 |
.97 |
1.03 |
1.00 |
1.04 |
|
| Cyp3a25 |  |
NM_019792 |
cytochrome P450, family 3, subfamily a, polypeptide 25 (Cyp3a25), mRNA [NM_019792] |
KLA | 1.00 |
.96 |
1.01 |
1.04 |
.99 |
.99 |
1.01 |
| ATP | 1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.93 |
.95 |
| KLA/ATP | .97 |
1.09 |
1.04 |
1.01 |
.99 |
.97 |
.97 |
|
Cyp3a41a
|  |
NM_017396 |
cytochrome P450, family 3, subfamily a, polypeptide 41A (Cyp3a41a), mRNA [NM_017396] |
KLA | 1.02 |
.99 |
.98 |
.95 |
.93 |
.93 |
1.06 |
| ATP | 1.00 |
.96 |
1.02 |
.97 |
.97 |
.95 |
1.02 |
| KLA/ATP | 1.03 |
1.02 |
1.07 |
.97 |
.93 |
.97 |
.97 |
|
| Cyp3a44 |  |
NM_177380 |
cytochrome P450, family 3, subfamily a, polypeptide 44 (Cyp3a44), mRNA [NM_177380] |
KLA | 1.05 |
1.03 |
1.05 |
1.02 |
1.08 |
1.00 |
1.03 |
| ATP | .97 |
1.00 |
1.03 |
1.07 |
.99 |
.99 |
.99 |
| KLA/ATP | 1.04 |
.99 |
.99 |
1.06 |
1.04 |
1.06 |
1.00 |
|
| Hrasls3 |  |
AK052657 |
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657] |
KLA | 4.07 |
4.01 |
2.57 |
2.26 |
1.94 |
1.66 |
1.10 |
| ATP | .93 |
.92 |
1.00 |
.96 |
.95 |
.99 |
1.08 |
| KLA/ATP | 3.36 |
2.63 |
1.76 |
1.26 |
1.41 |
1.22 |
1.27 |
|
| Hrasls3 | |
NM_139269 |
HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269] |
KLA | 11.37 |
10.85 |
12.50 |
16.13 |
13.98 |
17.12 |
6.64 |
| ATP | .86 |
.78 |
.96 |
.89 |
.84 |
.99 |
1.03 |
| KLA/ATP | 8.90 |
10.50 |
15.81 |
13.10 |
11.95 |
11.16 |
10.19 |
|
Mm.16006
7 |  |
124487226 |
Unknown |
KLA | .90 |
.88 |
.87 |
.85 |
.80 |
.85 |
.64 |
| ATP | .95 |
.95 |
1.00 |
.94 |
1.00 |
.91 |
.67 |
| KLA/ATP | .89 |
.86 |
.93 |
.82 |
.85 |
.84 |
.63 |
|
Mm.26915
|  |
51921286 |
Unknown |
KLA | 1.02 |
1.03 |
.96 |
1.11 |
1.05 |
.96 |
.96 |
| ATP | 1.02 |
1.00 |
.98 |
1.06 |
1.04 |
.99 |
1.08 |
| KLA/ATP | .96 |
.94 |
1.06 |
1.00 |
1.02 |
1.00 |
1.03 |
|
Mm.33050
7 |  |
67906182 |
Unknown |
KLA | .94 |
.98 |
.99 |
1.03 |
1.05 |
1.07 |
.98 |
| ATP | .95 |
1.02 |
.97 |
.98 |
.99 |
1.05 |
1.02 |
| KLA/ATP | 1.02 |
1.05 |
1.01 |
1.03 |
.99 |
.98 |
.97 |
|
Mm.42607
7 |  |
58743309 |
Unknown |
KLA | .98 |
.93 |
1.04 |
1.03 |
.97 |
.98 |
1.16 |
| ATP | 1.02 |
.95 |
1.02 |
1.06 |
.96 |
.95 |
1.04 |
| KLA/ATP | .98 |
.97 |
.98 |
1.01 |
.99 |
1.11 |
.91 |
|
Mm.71913
|  |
118130231 |
Unknown |
KLA | .93 |
1.00 |
1.06 |
.97 |
.95 |
.98 |
1.04 |
| ATP | 1.00 |
.98 |
1.08 |
1.02 |
.92 |
.90 |
.99 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.99 |
.99 |
.99 |
1.01 |
|
| Pla2g10 |  |
NM_011987 |
phospholipase A2, group X (Pla2g10), mRNA [NM_011987] |
KLA | .99 |
1.11 |
1.02 |
.99 |
1.00 |
1.01 |
1.02 |
| ATP | 1.02 |
.97 |
1.01 |
1.03 |
1.00 |
1.02 |
1.04 |
| KLA/ATP | 1.04 |
.96 |
.95 |
1.04 |
1.06 |
1.05 |
1.01 |
|
Pla2g12a
|  |
NM_023196 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] |
KLA | 1.03 |
1.06 |
.97 |
1.00 |
.78 |
.75 |
.92 |
| ATP | .91 |
.99 |
1.29 |
1.30 |
1.20 |
1.48 |
1.71 |
| KLA/ATP | .92 |
.99 |
1.19 |
1.16 |
1.06 |
1.12 |
1.36 |
|
Pla2g12a
| |
NM_183423 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] |
KLA | .90 |
1.00 |
.87 |
.95 |
.76 |
.68 |
.88 |
| ATP | .96 |
.94 |
1.26 |
1.24 |
1.19 |
1.47 |
1.88 |
| KLA/ATP | .89 |
.90 |
1.08 |
1.07 |
1.06 |
1.02 |
1.59 |
|
Pla2g12b
|  |
NM_023530 |
phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] |
KLA | .98 |
.95 |
1.05 |
.99 |
1.03 |
.99 |
.94 |
| ATP | 1.02 |
1.04 |
1.07 |
1.05 |
.92 |
1.04 |
1.00 |
| KLA/ATP | .98 |
.92 |
1.10 |
1.11 |
1.09 |
1.03 |
1.04 |
|
| Pla2g1b |  |
NM_011107 |
phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] |
KLA | 1.00 |
1.01 |
1.01 |
1.11 |
1.00 |
1.28 |
1.00 |
| ATP | .98 |
1.03 |
1.09 |
1.03 |
1.01 |
1.02 |
1.04 |
| KLA/ATP | .93 |
.94 |
1.01 |
1.00 |
.94 |
1.09 |
1.07 |
|
| Pla2g2a |  |
NM_001082531 |
phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] |
KLA | 1.08 |
.99 |
1.00 |
1.06 |
.98 |
1.01 |
.94 |
| ATP | 1.07 |
.98 |
1.04 |
1.06 |
.90 |
.98 |
.98 |
| KLA/ATP | .98 |
1.03 |
1.00 |
1.04 |
.94 |
.97 |
.96 |
|
| Pla2g2c |  |
NM_008868 |
phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] |
KLA | .98 |
.99 |
1.05 |
.98 |
1.01 |
1.00 |
1.04 |
| ATP | 1.08 |
1.06 |
1.09 |
.93 |
.92 |
.92 |
1.00 |
| KLA/ATP | 1.03 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
1.02 |
|
| Pla2g2d |  |
NM_011109 |
phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] |
KLA | 1.02 |
1.02 |
.99 |
.99 |
1.00 |
1.01 |
1.00 |
| ATP | .95 |
1.11 |
1.10 |
1.11 |
.98 |
.99 |
1.12 |
| KLA/ATP | 1.02 |
1.00 |
1.19 |
1.11 |
1.00 |
.96 |
1.01 |
|
| Pla2g2e |  |
NM_012044 |
phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] |
KLA | .78 |
.75 |
.74 |
.72 |
.62 |
.69 |
1.40 |
| ATP | 1.06 |
1.00 |
.92 |
1.04 |
.83 |
.76 |
3.74 |
| KLA/ATP | .78 |
.80 |
.69 |
.74 |
.70 |
.74 |
2.24 |
|
| Pla2g2f |  |
NM_012045 |
phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] |
KLA | 1.02 |
.99 |
1.03 |
1.01 |
1.00 |
.95 |
.99 |
| ATP | 1.01 |
1.06 |
1.11 |
.97 |
1.09 |
1.11 |
.99 |
| KLA/ATP | 1.10 |
1.05 |
1.04 |
.95 |
1.04 |
1.01 |
.96 |
|
| Pla2g3 |  |
NM_172791 |
phospholipase A2, group III (Pla2g3), mRNA [NM_172791] |
KLA | 1.04 |
1.05 |
1.02 |
1.01 |
1.04 |
1.11 |
1.00 |
| ATP | .96 |
.97 |
1.10 |
.91 |
.99 |
.97 |
1.08 |
| KLA/ATP | 1.03 |
1.11 |
1.10 |
.98 |
.95 |
.98 |
1.07 |
|
| Pla2g4a |  |
NM_008869 |
phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] |
KLA | 3.93 |
4.49 |
4.86 |
6.40 |
6.44 |
3.10 |
1.68 |
| ATP | 1.13 |
1.36 |
1.27 |
1.30 |
1.02 |
5.37 |
1.47 |
| KLA/ATP | 3.64 |
4.45 |
4.76 |
7.11 |
2.96 |
4.08 |
2.60 |
|
| Pla2g4b |  |
NM_145378 |
phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] |
KLA | 1.09 |
1.18 |
.95 |
1.01 |
.97 |
.97 |
.77 |
| ATP | 1.05 |
1.14 |
1.28 |
.94 |
.88 |
1.18 |
.70 |
| KLA/ATP | 1.23 |
1.43 |
1.21 |
1.02 |
1.15 |
1.16 |
.78 |
|
| Pla2g4c |  |
AK145339 |
1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] |
KLA | 1.09 |
1.21 |
1.33 |
1.17 |
1.26 |
1.30 |
1.05 |
| ATP | .97 |
1.06 |
1.00 |
.98 |
.98 |
.98 |
1.05 |
| KLA/ATP | 1.19 |
1.16 |
1.18 |
1.13 |
1.04 |
1.02 |
1.06 |
|
| Pla2g4c | |
NM_001004762 |
phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] |
KLA | .93 |
1.00 |
.94 |
.93 |
.94 |
.94 |
.96 |
| ATP | .98 |
.96 |
1.13 |
.97 |
.99 |
.89 |
.96 |
| KLA/ATP | 1.01 |
1.01 |
1.07 |
1.01 |
.94 |
1.01 |
.92 |
|
| Pla2g4e |  |
AK049063 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] |
KLA | 1.03 |
1.09 |
1.01 |
1.01 |
1.06 |
.94 |
1.05 |
| ATP | 1.03 |
1.00 |
1.06 |
1.01 |
.96 |
1.05 |
1.05 |
| KLA/ATP | .98 |
1.00 |
1.01 |
.98 |
1.03 |
.95 |
1.01 |
|
| Pla2g4e | |
NM_177845 |
phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] |
KLA | .97 |
.95 |
1.01 |
.97 |
1.02 |
1.03 |
1.05 |
| ATP | .98 |
.99 |
1.00 |
1.10 |
.98 |
1.00 |
1.02 |
| KLA/ATP | 1.05 |
.93 |
.96 |
1.03 |
1.08 |
1.05 |
.99 |
|
| Pla2g4f |  |
NM_001024145 |
phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] |
KLA | 1.08 |
.99 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
| ATP | .99 |
1.04 |
.99 |
1.03 |
1.12 |
1.01 |
1.25 |
| KLA/ATP | .97 |
1.04 |
1.10 |
1.06 |
1.04 |
1.03 |
1.03 |
|
| Pla2g5 |  |
NM_011110 |
phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] |
KLA | .65 |
.62 |
.56 |
.53 |
.62 |
1.60 |
3.01 |
| ATP | .90 |
.82 |
.88 |
1.69 |
1.82 |
1.26 |
6.32 |
| KLA/ATP | .63 |
.59 |
.65 |
.63 |
.91 |
1.56 |
5.59 |
|
| Pla2g6 |  |
NM_016915 |
phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] |
KLA | .60 |
.59 |
.56 |
.60 |
.94 |
1.31 |
1.59 |
| ATP | 1.10 |
1.14 |
.95 |
1.05 |
1.06 |
1.13 |
1.14 |
| KLA/ATP | .63 |
.56 |
.54 |
.56 |
.71 |
.97 |
1.55 |
|
| Plb1 |  |
AK015993 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] |
KLA | .99 |
.99 |
1.05 |
1.02 |
1.03 |
1.07 |
1.02 |
| ATP | 1.04 |
1.03 |
1.07 |
1.06 |
1.09 |
1.01 |
1.02 |
| KLA/ATP | 1.07 |
1.00 |
.96 |
1.09 |
1.05 |
1.08 |
1.01 |
|
| Plb1 | |
AK087596 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] |
KLA | .93 |
.99 |
.99 |
1.07 |
.98 |
1.00 |
.98 |
| ATP | 1.08 |
1.00 |
.97 |
1.07 |
1.04 |
1.09 |
.96 |
| KLA/ATP | 1.06 |
.96 |
1.00 |
.98 |
1.04 |
1.06 |
.98 |
|
| Plb1 | |
NM_001081407 |
phospholipase B1 (Plb1), mRNA [NM_001081407] |
KLA | 1.05 |
1.09 |
1.05 |
1.04 |
1.05 |
1.03 |
.85 |
| ATP | .96 |
1.03 |
1.02 |
.95 |
1.06 |
1.01 |
.92 |
| KLA/ATP | 1.00 |
1.00 |
1.09 |
1.00 |
.97 |
.99 |
.86 |
|
|
ATP
ATP+KLA